Byoung Chul Cho, MD, PhD, Yonsei Cancer Center at Yonsei University College of Medicine
Advertisement
Articles by Byoung Chul Cho, MD, PhD, Yonsei Cancer Center at Yonsei University College of Medicine
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
3
Subgroup Analyses Confirm Clinically Meaningful Revumenib Responses in AML Across Mutational Profiles
4
Data Support Luspatercept at Maximum-Approved Dose for Transfusion-Dependent Lower-Risk MDS
5